Public Companies
Payton Nyquvest, CEO of Numinus, Sits in the Investor Hotseat on September 29th
Numinus ($NUMI) CEO, Payton Nyquvest, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments. Numinus empowers…
Numinus ($NUMI) CEO, Payton Nyquvest, joins the Investor Hotseat to field hot questions from host, Dustin Robinson of Iter Investments.
Numinus empowers people to heal and be well through developing and delivering innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. Payton deeply understands the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple therapeutic modalities. Additionally, Payton has deep business leadership experience, particularly in the finance sector, and is a recognized innovator and visionary in mental health care.
Can Payton handle the Hotseat?
As always, this will be a live event. You’ll be able to stream it from the Psychedelic Invest website, YouTube, LinkedIn, Facebook, Twitch, and Twitter. If you miss it, though, don’t worry. It will be recorded and available across those channels after the event.
If you’d like to attend the live event, you can set a reminder on Youtube or LinkedIn. Or, you can come back to the Hotseat livestream page at the time of the event.
To RSVP to ensure your spot, please fill out the form below.
A Transcription Will Be Available Following the Event
-
Law & Regulation1 week ago
Relmada Therapeutics trims losses, slashes research costs
-
Psychedelics1 week ago
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
-
Psychedelics1 week ago
Elon Musk Continues To Defend Ketamine
-
Psychedelics1 week ago
Numinus Wellness Submits Clinical Trial Application
-
Psychedelics1 week ago
Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
-
Psychedelics1 week ago
MindBio Therapeutics Corp. Begins Phase 2B Take-Home Microdosing Clinical Trial in Patients with Major Depressive Disorder
-
Psilocybin6 days ago
Indigenous Psilocybin Practices Around the World
-
Psychedelics1 week ago
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas